TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT01060254

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Form=solution for injection, route=Subcutaneous injection. One injection of matching placebo every 28 days for up to 12 wks

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JNJ-42160443
Description: Type=exact number, unit=mg, number= 9, form=solution for injection, route=Subcutaneous use. One injection of 9 mg of JNJ-42160443 every 28 days for up to 12 wks
Study: NCT03822507

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: KHK7580
Description: oral administration

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cinacalcet Hydrochloride
Description: oral administration
Study: NCT00127036

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: XELOX
Description: XELOX: Oxaliplatin 130 mg/m\^2 intravenously (IV); Capecitabine 825 mg/m\^2 by mouth (po)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: XELIRI
Description: XELIRI: Irinotecan 240 mg/m\^2 IV; Capecitabine 825 mg/m\^2 by mouth (po)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Description: 7.5 mg/kg intravenously (IV)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Description: 7.5 mg/kg intravenously (IV)
Study: NCT01855074

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Risperidone
Description: Risperidone 25 milligram (mg) will be given as intramuscular injection for every 2 weeks up to 6 months. Participants with persistent symptoms and/or requiring higher doses of antipsychotics will be administered higher doses of risperidone. Doses will be adjusted as per Investigator's discretion.
Study: NCT01432418

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Wheelchair skills training program
Description: A training program that uses methods based on the rehabilitation, wheelchair, and motor skills literature to teach wheelchair skills.
Study: NCT02651454

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Daesiho-tang
Description: Usage: 6g, three times a day, each taken before or between meals for 12 weeks Manufacturing company: HANPOONG PHARM \& FOODS Co. Ltd.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chowiseungcheng-tang
Description: Usage: 6g, three times a day, each taken before or between meals for 12 weeks Manufacturing company: Hanzung Pharmaceutical. co. Ltd.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Usage: 6g, three times a day, each taken before or between meals for 12 weeks Manufacturing company: HANPOONG PHARM \& FOODS Co. Ltd.
Study: NCT00872885

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GRT6005
Description: liquid formulation, 200 to 600 µg, single dose, one day

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GRT6005
Description: liquid formulation, 200 to 600 µg, single dose, one day

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GRT6005
Description: liquid formulation, 200 to 600 µg, single dose, one day

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Morphine
Description: 60 mg

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: single dosage
Study: NCT00031499

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Azithromycin
Description: Single 2 gram oral dose (4 tablets) at Day 1.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Benzathine Penicillin
Description: Supplied in pre-filled syringes containing 1.2 million units of benzathine penicillin; 2.4 million units administered intramuscularly at Day 1, in one or both buttocks.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Doxycycline
Description: Baseline visit, 28 capsules dispensed, for a dose of 100 mg twice a day (BID).
Study: NCT00377429

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: catumaxomab
Description: Catumaxomab administered as four 3-hour, constant-rate, intraperitoneal (IP) infusions of 10, 20, 50, 150 microgram (mcg).
Study: NCT03258697

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Levobupivacaine Hydrochloride
Description: Different way of LevoBupivacaine injection

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Levobupivacaine Hydrochloride
Description: Different way of LevoBupivacaine injection
Study: NCT02190617

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Enhanced Clinic+ Unified Plan + CHW
Description: * Unified asthma management plan and asthma support team coordination: A support team will partner with each patient to develop a single asthma management plan. An EMR will provide a web-based platform for sharing the unified asthma management plan.~* Home visit intervention: Community health workers will provide in-home tailored asthma support and conduct follow-up to support patient actions to improve asthma control based on unified asthma management plan.~* Enhanced clinic intervention: Intervention clinics will implement a multicomponent intervention that will include decision support, audit and feedback, provider and staff education, asthma champions, team-based care, and spirometry, all supported by EMR enhancements and clinic systems redesign.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Enhanced Clinic+ Unified Management Plan
Description: * Unified asthma management plan and asthma support team coordination: A support team (clinicians, CHWs and plan care managers) will partner with each patient to develop a single asthma management plan. An EMR will provide a web-based platform for sharing the unified asthma management plan and enhancing communications among care team.~* Enhanced clinic intervention: Intervention clinics will implement a multicomponent intervention that will include decision support, audit and feedback, provider and staff education, asthma champions, team-based care, and spirometry, all supported by EMR enhancements and clinic systems redesign.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: CHW Home Visit Only
Description: -Home visit intervention: Community health workers will provide in-home tailored asthma support: assess asthma self-management knowledge and skills, conduct a home environmental assessment focused on asthma triggers, and conduct follow-up visits to support patient actions to improve asthma control based on unified asthma management plan.
Study: NCT00602277

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Laboratory Biomarker Analysis
Description: Correlative studies

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Wild-type Reovirus
Study: NCT01648829

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Atorvastatin
Description: Patients will receive randomly atorvastatin (20 mg day) for 30 days

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pitavastatin
Description: Patients will receive randomly pitavastatin (4 mg day) for 30 days
Study: NCT03879876

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Human T Lymphoid Progenitor (HTLP) injection
Description: Injection of progenitors derived from HTLP culture at Day 8-Day 12 after partially HLA compatible allogeneic hematopoietic stem cell transplantation in SCID patients (Day7 of culture)
Study: NCT04029987

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Bilateral Ultrasound-Guided Transmuscular Quadratus Lumborum Block.
Description: A 22 G echogenic needle will be inserted in plane from the posterior (medial) end of the probe and directed for the fascial plane between the Quadratus Lumborum and the Psoa Major muscles through the Quadratus Lumborum muscle. Once the needle is confirmed in correct location, 1 mL of saline will be injected after negative aspiration. Then 0.5 mL/Kg of bupivacaine 0.25% will be injected. The spread of the injectate should be observed to distribute within this plane. This technique will be repeated to the other side.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Bilateral Ultrasound-Guided intra smuscular Quadratus Lumborum Block.
Description: A 22 G echogenic needle will be inserted in plane from ventral (lateral) edge of the probe and advanced until penetration of QL muscle fascia is observed. Once the needle is confirmed in correct location, 1 mL of saline will be injected after negative aspiration. Then 0.5 mL/Kg of bupivacaine 0.25% will be injected. The spread of the injectate should be observed to distribute within this plane. This technique will be repeated to the other side.

Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Control
Description: Conventional analgesia
Study: NCT02058082

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Intracytoplasmic sperm injection
Study: NCT01261975

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Coaxial Micro-Incision Cataract Surgery
Description: 1.8 mm coaxial micro incision

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Coaxial Small Incision Cataract Surgery
Description: 2.75 mm coaxial incision
Study: NCT01722929

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Skin sensor

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Skin sensor
Study: NCT03348293

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: 3D printing
Description: Scope of tumor resection was simulated according to the MR imaging data. After meticulous design, we created the personalized porous biodegradable scaffold and printed by 3D printer, using porous PCL biomaterials. During operation, the biodegradable scaffold was implanted into the defective cavity after tumor resection.
Study: NCT01642303

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: vodcasting
Description: listening to downloaded vodcasting files
Study: NCT02626741

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: meal replacement group
Description: The participants will receive SlimWell 60 grams per meal for 2 meals per day plus life style modification including educational sessions of exercise, dietary intake, food record. The duration is 3 months.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: control group
Description: The participants will receive only life style modification including educational sessions of exercise, dietary intake, food record. The duration is 3 months.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: control group
Description: The participants will receive only life style modification including educational sessions of exercise, dietary intake, food record. The duration is 3 months.
Study: NCT04649762

Intervention type: BEHAVIORAL
Intervention: activating consciousness technique (hypnosis)
Description: activating consciousness technique (hypnosis)
Study: NCT01379924

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Parenting/Life Skills Intervention
Description: Modules adapted from the Ansell-Casey Life Skills Assessment Curriculum, the Women's Negotiation Project Curriculum for Teen Mothers and the Nurturing Curriculum. Goal is to help teen mothers develop positive parenting skills, decrease repeat pregnancy and acquire skills of daily living. The series of five, one-hour long, structured, one-on-one interactive modules aims to help teens build positive, empathetic relationships with their children, while enhancing self-efficacy and increasing the sense of self- worth for parents and children. Domains addressed include child development/discipline, safety, house/money management, social relationships, career planning, substance abuse and community and interpersonal violence.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Teen-tot medical home
Description: Medical, mental health, and social services provided to teen parents and their children
Study: NCT02128984

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Symbiotic Formula with DHA and antioxidants
Description: 6 months intervention.

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Standard Formula
Description: 6 months intervention.
Study: NCT01066884

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: erlotinib [Tarceva]
Description: 150mg po daily
Study: NCT00801359

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Phacoemulsification

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Phacoemulsification
Study: NCT01440907

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Care Coordination Program
Description: The Care Coordination Program includes: (1) access to a secure online personal health record (PHR) that people can logon and manage their health information, as well as receive alerts and reminders about action items for them to take on their healthcare; and (2) depending on the patient's health care needs, nursing support (either in-person or by phone).
Study: NCT03962556

Intervention type: OTHER
Intervention: bimanual palpation
Description: bimanual palpation....i..

Intervention type: OTHER
Intervention: bimanual palpation
Description: bimanual palpation....i..
Study: NCT00699842

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenalidomide
Description: Dose Level Lenalidomide Schedule~1. 15mg/day for d1-21 out of 28 days~2. 20mg/day for d1-21 out of 28 days~3. 25mg/day for d1-21 out of 28 days
Study: NCT02016898

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Placement of the sponge

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mitomycin-C

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mitomycin-C
Study: NCT00098020

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Isotretinoin
Study: NCT01926847

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Riociguat (Adempas, BAY63-2521)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Riociguat (Adempas, BAY63-2521)
Study: NCT00801359

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: BSSPlus solution

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lactated Ringer's solution
Study: NCT04031781

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: repetitive transcranial magnetic stimulation (rTMS) 100% motor threshold
Description: Each rTMS session consisted of a single train of 900 total pulses over 3 minutes duration.

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: repetitive transcranial magnetic stimulation (rTMS) 50% motor threshold
Description: Each rTMS session consisted of a single train of 900 total pulses over 3 minutes duration.
Study: NCT01926847

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Study: NCT01833741

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bimatoprost 0.01%
Description: Bimatoprost 0.01% (LUMIGAN® RC) administered as one drop in the study eye(s) each evening for 12 weeks.
Study: NCT01738737

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Active Laser
Description: 18 points of application of active laser in the knee (frontal faces, lateral and medial)

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Active Laser
Description: 18 points of application of active laser in the knee (frontal faces, lateral and medial)

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Stretching exercises
Description: 7 stretching exercises for lower limbs lasting 30 seconds with 4 repetitions

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Stretching exercises
Description: 7 stretching exercises for lower limbs lasting 30 seconds with 4 repetitions

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Stretching exercises
Description: 7 stretching exercises for lower limbs lasting 30 seconds with 4 repetitions

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: placebo laser therapy
Description: 18 points of application of placebo laser in the knee (frontal faces, lateral and medial)
Study: NCT00944268

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Passiflora, Crataegus e Salix
Description: Comparison of different pharmaceutics forms of drug
Study: NCT01642303

Intervention type: OTHER
Group type: NO_INTERVENTION
Intervention: no intervension
Description: Listen to student book listening files
Study: NCT03519672

Intervention type: OTHER
Intervention: No intervention
Description: This is a non-interventional study.

Intervention type: OTHER
Intervention: No intervention
Description: This is a non-interventional study.
Study: NCT04019769

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: L-glutamine
Description: product will be obtained by Endari and administered by NIH pharmacy. Patient will take supplement as prescribed
Study: NCT01626053

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ASMART
Description: Motivational Interviewing, Stages of Change, Psychological Testing, Bio-psychosocial assessment, responsive diabetes education, support, Cognitive-behavioral interventions

Intervention type: OTHER
Group type: NO_INTERVENTION
Intervention: Control Group
Description: no intervention
Study: NCT01819506

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Task Practice Physical Rehabilitation Therapy
Description: Similar to stroke rehabilitation occupational therapy.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Task Practice Physical Rehabilitation Therapy
Description: Similar to stroke rehabilitation occupational therapy.
Study: NCT02827279

Intervention type: OTHER
Group type: OTHER
Intervention: emotional induction
Description: The eye-tracking mesure the reaction at emotional induction using of sound stimuli in a group of children with or without ASD, in a context of

Intervention type: OTHER
Group type: OTHER
Intervention: emotional induction
Description: The eye-tracking mesure the reaction at emotional induction using of sound stimuli in a group of children with or without ASD, in a context of
Study: NCT01729650

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physical and diet educational group
Description: educational group of: physical activity program (basically walking) of 24 sessions over 12 weeks, and diet (16 sessions in the first 8 weeks, carried out by mental health nurses.
Study: NCT03155633

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Athletics track
Description: Running at 95-105% aerobic Threshold on athletics track 48h, 96h, 144h after the race. Control heart devices

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Elliptical machine
Description: Running at 95-105% aerobic Threshold on elliptical machine 48h, 96h, 144h after the race. Control heart devices
Study: NCT04164329

Intervention type: DRUG
Intervention: General anesthetic
Description: General anesthesia (propofol, fentanyl, sevorane, remifentanyl, rocuronium)
Study: NCT02173392

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Brodalumab
Description: Brodalumab is a large molecule for the treatment of inflammatory diseases

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Brodalumab
Description: Brodalumab is a large molecule for the treatment of inflammatory diseases
Study: NCT02277522

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: RNA anti-CD19 CAR T cells
Description: intravenously administered, RNA electroporated autologous T cells expressing CD19 chimeric antigen receptors expressing tandem TCRζ and 4-1BB (TCR /4-1BB) costimulatory domains (referred to as RNA CART19)
Study: NCT04975542

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Osteopathic Manipulative Medicine
Description: Manipulative therapies based on Osteopathic principles.

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham
Description: Light touch techniques to mimic to osteopathic treatment.
Study: NCT01471964

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MLN8237 and Erlotinib
Description: Erlotinib pills once every day and MLN8237 pills twice every day, day 1-7 of every 21 days
Study: NCT03427138

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Jasper
Description: Families in the joint attention intervention will receive 10 weeks of the JASPER (Joint Attention Symbolic Play Engagement Regulation) protocol. JASPER is a treatment approach based on a combination of developmental and behavioral principles developed by Dr. Connie Kasari at the Center for Autism Research and Treatment, at University of California, Los Angeles. Our research staff will be trained on the specific techniques of JASPER guided by Connie Kasari (consultant on project) and her colleagues The study's intervention involves 2 days/week of 60-minute sessions with a trained experimenter (which may take place in the lab or home, depending on the needs of the family). The primary goal for the intervention will be to increase the frequency and range/variety of joint attention and to advance the child to higher levels (e.g., from requesting to initiating joint attention acts).
Study: NCT01043718

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: More-Intensive
Description: The online lifestyle intervention will include elements of a behavioral lifestyle program developed by the Diabetes Prevention Program. The program will assist individual participants with establishing appropriate weight loss goals, implementing dietary recommendations (including analysis of current diet), and defining exercise programs. The program curriculum provides standard information about healthy lifestyle, and behavioral techniques for integrating them into daily living. In each lesson, patients provide feedback about how they interpret the information, and ideas for integrating it into their lives.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Less-Intensive
Description: The participants will be provided with the information to access the online Diabetes Prevention Program (DPP) intervention materials. Following the original DPP trial, all DPP materials were placed online for the public to access. This group will receive a lifestyle counseling session and tools to facilitate their intervention.
Study: NCT03294005

Intervention type: DIAGNOSTIC_TEST
Intervention: Thyroid ultrasonography
Description: Each subject had been transverse and longitudinal views of thyroid ultrasonography with high-resolution ultrasound (7-14 MHz) (HP Image Point-HS, Toshiba SSA250, GE ,Aloka SSD-1200 and Siemens S2000) that was performed by our partners - endocrinologist in all patients.
Study: NCT03427138

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Parent Education
Description: Families in the parent education intervention. Parent education will be provided in group sessions. During the sessions information is presented about ASD, how to deal with behavioral difficulties and available services, and parents are given an opportunity to share experiences. Parents will attend a weekly session for 10 weeks. 10 different topics will be discussed, which include: causes and symptoms of autism, diagnosis process, treatment options, enhancing communicative abilities in children with autism, emotion regulation, dealing with distress, correcting behavior difficulties, applying structure and routines.